CompletedNCT04416061COVID-19Updated Feb 28, 2024

The Role of a Private Hospital in Hong Kong Amid COVID-19 Pandemic

An observational study in COVID, sponsored by Hong Kong Sanatorium & Hospital. Completed at 1 site in Hong Kong. Per ClinicalTrials.gov, last updated 2024-02-28.

Sponsored by Hong Kong Sanatorium & Hospital · Observational

Study type: Observational
Model: Cohort
Time perspective: Retrospective
Enrollment: 2,510
Sex: All

Study summary

Hong Kong public healthcare system is facing tremendous pressure under the COVID-19 pandemic. As the virus spread in Hong Kong, Hong Kong Sanatorium \& Hospital (HKSH) is one of the first private hospitals which immediately provide reliable and rapid COVID-19 test -- Reverse Transcription Polymerase Chain Reaction (RT-PCR). Early provision of the RT-PCR screening test for COVID-19 not only facilitates identification of COVID-19 but also contains the spread of the virus in the community and frontline medical staff.

Since description of role of private hospital in Hong Kong amid COVID-19 pandemic is lacking, this study will describe COVID-19 screening algorithm and methodology. A retrospective analysis on clinical characteristics, laboratory findings as well as outcome of patients who underwent COVID-19 test in HKSH is also performed.

Conditions studied

COVID

In context

Lead sponsor

Hong Kong Sanatorium & Hospital is the lead sponsor of 9 studies on the registry; 1 is open to participants now.

Counted across the registry records on this site, refreshed daily.

Who can participate

Ages eligible: Child (0–17), Adult (18–64), Older adult (65+)
Sexes eligible: All
Accepts healthy volunteers: No
Sampling method: Probability sample

Study population

Subjects who underwent COVID-19 test in HKSH during the study period

Inclusion criteria

Subjects who underwent COVID-19 test in HKSH during the study period

Exclusion criteria

Exclusion Criteria:

Study design

Observational model: Cohort
Time perspective: Retrospective
Enrollment: 2,510 participants (actual)
Patient registry: No

Groups and cohorts

Subjects underwent COVID-19 test
Subjects who underwent COVID-19 test in HKSH during the study period
Diagnostic Test: COVID 19 Diagnostic Test

Interventions

Diagnostic testCOVID 19 Diagnostic Test
COVID 19 Diagnostic Test

What researchers measure

Primary outcomes

Proportion of asymptomatic subjects
Proportion of asymptomatic subjects (%) who underwent COVID 19 test
Time frame: 1 Feb 2020 until the 14th consecutive day without any local infection in Hong Kong

Secondary outcomes

Proportion of subjects with recent contact history
Proportion of subjects (%) with recent contact history
Time frame: 1 Feb 2020 until the 14th consecutive day without any local infection in Hong Kong
Proportion of subjects with recent travel history
Proportion of subjects (%) with recent travel history
Time frame: 1 Feb 2020 until the 14th consecutive day without any local infection in Hong Kong

Study locations

1 site

Hong Kong Sanatorium & Hospital
Hong Kong, Hong Kong

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

Timeline

Tracking since Sep 25, 2026

ElapsedEstimatedEstimated, not yet reached

Ran from May 2020 to primary completion in Jul 2020, 2 months.

How these figures are worked out, and which studies are left out of them.

Registered: Jun 1, 2020
First posted: Jun 4, 2020
StartActual: May 11, 2020
Primary completionActual: Jul 31, 2020
CompletionActual: Jul 31, 2020
Last update: Feb 28, 2024

What these dates mean

Start.: When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.: When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.: When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.: Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.

No changes since tracking began. The registry record was last updated on Feb 28, 2024, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗

Registry details

Key details

Study ID: NCT04416061
Lead sponsor: Hong Kong Sanatorium & Hospital
Responsible party: Dr. Jonpaul ST Zee (Specialist in Infectious Disease, Hong Kong Sanatorium & Hospital) — Principal investigator
First posted: Jun 4, 2020
Start date: May 11, 2020
Primary completion: Jul 31, 2020
Completion: Jul 31, 2020
Last update: Feb 28, 2024

Study contacts

Jonpaul Sze Tsing Zee, MBChB

principal investigator · Hong Kong Sanatorium & Hospital

Oversight

FDA-regulated drug: No
FDA-regulated device: No

View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Feb 2024. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Other studies from this sponsor

Hong Kong Sanatorium & Hospital

Start the discussion